Amicus Therapeutics Inc (FOLD)
EBITDA Margin
8.48%
TTM · Period ending:
FOLD EBITDA Margin
Latest reported8.48%period ending
Latest reported8.48%period ending
FOLD TTM EBITDA Margin (-2498.21% → 8.48%)
TTM ebitda margin
High-resolution chart · PNG
FOLD ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 8.4846% | |
| 9.9006% | |
| 5.7887% | |
| 9.8739% | |
| 5.563% | |
| -1.8626% | |
| -8.8517% | |
| -19.116% | |
| -23.0569% | |
| -35.7443% | |
| -40.4972% | |
| -49.8245% | |
| -60.6191% | |
| -65.7361% | |
| -73.161% | |
| -69.3085% | |
| -66.4042% | |
| -66.3523% | |
| -73.8914% | |
| -80.3616% | |
| -93.1376% | |
| -107.821% | |
| -117.9749% | |
| -145.0157% | |
| -182.3247% | |
| -197.3143% | |
| -313.0502% | |
| -358.4916% | |
| -353.41% | |
| -435.6471% | |
| -693.7272% | |
| -866.209% | |
| -1,170.7907% | |
| -1,705.9923% | |
| -1,205.4406% | |
| -2,210.4963% | |
| -3,912.9084% | |
| -8,224.0715% | |
| 8,891.2582% | |
| 9,439.5274% | |
| 16,515.3509% | |
| -3,771.8346% | |
| -4,335.3941% | |
| -6,974.359% | |
| -16,240.4959% | |
| -151,428.2051% | |
| -514.7034% | |
| -273.8254% | |
| -206.4265% | |
| -144.5256% | |
| -199.6945% | |
| -217.4256% | |
| -301.3572% | |
| -510.9627% | |
| -789.6922% | |
| -5,866.269% | |
| -8.9761% | |
| -4.4954% | |
| -7.9967% | |
| -6.4625% | |
| -271.5475% | |
| -269.0676% | |
| -276.8509% | |
| -283.7487% | |
| -332.2557% | |
| -500.3657% | |
| -881.877% | |
| -2,498.2063% |